Supplementary Figure 2B from A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report

Autor:	Susan M. Blaney, Frank M. Balis, Diana Stempak, Brenda Weigel, Michael Burke, Julia Glade Bender, Ashish M. Ingle, Peter C. Adamson, Sylvain Baruchel, Elizabeth Fox, AeRang Kim, Brigitte C. Widemann
Rok vydání:	2023
DOI:	10.1158/1078-0432.22446767
Popis:	PDF file, 39K, Plasma soluble VEGFR2 (A) and Placental Growth Factor (B) concentrations prior to therapy (baseline) and at the end of cycle 1 (steady state).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02abfa8f7551f5eea2c805f25c25f68e https://doi.org/10.1158/1078-0432.22446767 Zobrazit plný text záznamu